Late Breaking Abstract - ORAL FORMULATION OF ANGIOTENSIN-(1-7) PROMOTES RESOLUTION OF EOSINOPHILIC AND NEUTROPHILIC INFLAMMATION IN AN EXPERIMENTAL ASTHMA MODEL

A. Vasconcellos (Belo Horizonte, Brazil), J. Gregorio (Belo Horizonte, Brazil), I. Oliveira (Belo Horizonte, Brazil), A. Ribeiro (Belo Horizonte, Brazil), G. Nakashima (Belo Horizonte, Brazil), I. Baroni (Belo Horizonte, Brazil), L. Barcelos (Belo Horizonte, Brazil), R. Santos (Belo Horizonte, Brazil), M. Campagnole-Dos Santos (Belo Horizonte, Brazil), G. Magalhães (Belo Horizonte, Brazil), M. Rodrigues-Machado (Belo Horizonte, Brazil)

Source: International Congress 2019 – Modelling and monitoring of airway diseases
Session: Modelling and monitoring of airway diseases
Session type: Thematic Poster
Number: 4380

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Vasconcellos (Belo Horizonte, Brazil), J. Gregorio (Belo Horizonte, Brazil), I. Oliveira (Belo Horizonte, Brazil), A. Ribeiro (Belo Horizonte, Brazil), G. Nakashima (Belo Horizonte, Brazil), I. Baroni (Belo Horizonte, Brazil), L. Barcelos (Belo Horizonte, Brazil), R. Santos (Belo Horizonte, Brazil), M. Campagnole-Dos Santos (Belo Horizonte, Brazil), G. Magalhães (Belo Horizonte, Brazil), M. Rodrigues-Machado (Belo Horizonte, Brazil). Late Breaking Abstract - ORAL FORMULATION OF ANGIOTENSIN-(1-7) PROMOTES RESOLUTION OF EOSINOPHILIC AND NEUTROPHILIC INFLAMMATION IN AN EXPERIMENTAL ASTHMA MODEL. 4380

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: